Component

Lipase enzyme preparation

Species, preparation, dose and limitations are retained on linked claims.

1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What it acts on

  1. Lipase treatment removed the fatty-acid side chain of hericenone C to form deacylhericenone.

    Lipase enzyme preparation → Hericenone C source_derived_draftungraded
    Experimental context and source evidence
    dose
    Hericenone C with lipase
    duration
    Incubation interval specified in the primary article
    evidence_access
    Primary PubMed abstract and indexed metadata reviewed. Full-text method details not stated here remain unresolved.
    evidence_scope
    literature_reviewed; model-specific source-derived curation
    experimental_model
    Cell-free digestion followed by structural analysis
    limitations
    The preparation models possible metabolism but does not establish the responsible human digestive enzyme or in-vivo conversion fraction.
    nutrient_topic
    Hericenones & Erinacines chapter; interacting nutrients, drugs, peptides and proteins retain their experimental settings. · Hericenones and erinacines
    organism
    Cell-free digestion followed by structural analysis
    plain_language
    Lipase treatment removed the fatty-acid side chain of hericenone C to form deacylhericenone.
    primary_references
    Deacylated Derivative of Hericenone C Treated by Lipase Shows Enhanced Neuroprotective Properties Compared to Its Parent Compound. (2023). https://pubmed.ncbi.nlm.nih.gov/37299024/ DOI: 10.3390/molecules28114549
    route
    In vitro enzymatic treatment
    tissue
    Hericenone C deacylation

    Hericenones & Erinacines: mechanism of action and interactions (2026-09-20) · lines 66–75

    Original AI-assisted source-specific curation with primary-study citations, model, exposure, route, duration, negative findings and limitations preserved. Not publisher full text. · supports · Cell-free digestion followed by structural analysis · source_derived_draft · unverified_draft

    ## hericenones-erinacines-lipase-deacylation Lipase treatment removed the fatty-acid side chain of hericenone C to form deacylhericenone. Model/species: Cell-free digestion followed by structural analysis Tissue/system: Hericenone C deacylation Exposure: Hericenone C with lipase Route: In vitro enzymatic treatment Duration: Incubation interval specified in the primary article Limits: The preparation models possible metabolism but does not establish the responsible human digestive enzyme or in-vivo conversion fraction. Primary reference: Deacylated Derivative of Hericenone C Treated by Lipase Shows Enhanced Neuroprotective Properties Compared to Its Parent Compound. (2023). https://pubmed.ncbi.nlm.nih.gov/37299024/ DOI: 10.3390/molecules28114549 Access: Primary PubMed abstract and indexed metadata reviewed. Full-text method details not stated here remain unresolved.
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards